Med. praxi. 2016;13(4):171-174 | DOI: 10.36290/med.2016.035
What should a general practitioner know about the diagnosis and treatment of atrial fibrillation
- I. interní klinika &ndash, kardiologická, Fakultní nemocnice Olomouc
Management of nonvalvular atrial fibrillation is recommended by Guidelines for the management of Atrial Fibrillation of the Czech
Society of Cardiology (2011) and 2012 focused update of the ESC Guidelines for the management of atrial fibrillation (august 2012).
In diagnostics, we try to capture atrial fibrillation according to adequate symptoms or pathological findings suggestive of embolic
origin. Antithrombotic therapy is mainly ruled by the new thromboembolic risk stratification, so called CHA2DS2VASC score. New
anticoagulants are preferred for anticoagulant therapy unless optimal anticoagulation with warfarin. Presented antiarrhythmic
therapy is essentially unchanged, radiofrequency ablation is preferred for symptomatic paroxysmal form in patients without
structural heart disease.
Keywords: atrial fibrillation, CHA2DS2Vasc score, anticoagulation, antiarrhythmic therapy, radiofrequency ablation
Published: October 1, 2016 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
Heinc P, Kamasová M, Látal J, Kováčik F, Smékal A, Rec L. What should a general practitioner know about the diagnosis and treatment of atrial fibrillation. Med. praxi. 2016;13(4):171-174. doi: 10.36290/med.2016.035.
References
- Camm AJ, Kirchhof P, Lipp GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
Go to original source... - Čihák R, Heinc P, Haman L, et al. Doporučení pro... Fibrilace síní. Cor Vasa 2011; 53(1): 27-52. Go to original source...
- Camm AJ, Lipp GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33, 2719-2747.
- Čihák R, Haman L, Heinc P. Summary of the 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Prepared by the Czech Society of Cardiology, Cor et Vasa 54 (2012) e341-e351. Go to original source...
- Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010; 31: 967-975. Go to original source...
Go to PubMed... - Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006; 119: 448.e1-19. Go to original source...
- Lip GYH, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med 2010; 124: 111-114. Go to original source...
- Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093-1100. Go to original source... Go to PubMed...
- Patel MR, Mahaffey KW, Garg J, and the ROCKET AF Steering Committee for the ROCKET AF Investigators. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med 2011; 365: 883-891. Go to original source...
- Granger CB, Alexander JH, et al. for the ARISTOTLE Committees and Investigators. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2011; 365: 981-992. Go to original source...
- Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation:an analysis of the RE-LY trial. Lancet 2010; 376: 975-983. Go to original source...
- DeSantis G, Hogan-Schlientz J, Liska G, et al: STABLE results: Warfarin home monitoring achieves excellent INR control. Am. J. Managed Care 2014; 20: 202-209.
- Adam SS, McDuffie JR, Ortel TL, et al: Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: A systematic review. Ann Intern Med 2012; 157: 796-807. Go to original source...
- Morgan CL, McEwan P, Tukiendorf A, et al: Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res 2009; 124: 37-41. Go to original source...
- Van de Werf F, Brueckmann M, Connolly SJ, et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN). Am Heart J 2012; 163: 931-937. Go to original source... Go to PubMed...
- Winkelmayer WC, Liu J, Setoguchi S, et al. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 2011; 6: 2662-2668. Go to original source... Go to PubMed...
- Van Gelder IC, Groenveld HF, Crijns HJ et al. RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362: 1363-1373. Go to original source...
- Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. A randomized comparison of radiofrequency ablation and antiarrhythmia drug therapy as first line treatment in paroxysmal atrial fibrillation. N Engl J Med 2012; 367: 1587-1595. Go to original source... Go to PubMed...
- Shah RU, Freeman JV, Shilane D, et al. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012; 59: 143-149. Go to original source...